Ever since coronavirus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. From the market’s bearish low in mid-March, […]
Read MorePlus, Target and Kohl’s both delivered earnings beats, Taco Bell-owner Yum Brands bought an A.I. business to help it improve its marketing, and Instacart’s valuation has doubled.
Read MorePlus, jobless claims fell sharply last week amid harsh winter storms across the central U.S., an analyst says Moderna could soon see a $100 billion valuation, Wayfair reported an earnings miss, and Coinbase is going public.
Read MorePlus, the U.S. surpassed 500,000 deaths from COVID-19, Home Depot delivered an earnings beat, and Spotify is expanding into 85 more countries.
Read MoreThere is a lot of fundamental data that I rely on to help paint an overall picture about underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share, I prefer to expand my view of a company’s […]
Read MoreIt has been interesting to see how market commentary seems to have shifted as much as possible away from COVID-related news since the beginning of the year. In one sense, I think that could be a good thing, since there are a lot of issues, economic, political, and otherwise that are worthy of attention. This […]
Read MorePlus, last month’s GameStop saga is under the spotlight in Congress today, Walmart reported mixed earnings, and bitcoin surged above $52,000 for the first time.
Read MorePlus, Vir Biotechnology and GlaxoSmithKline are teaming up to develop an antibody treatment for the flu, Maersk is building carbon-neutral shipping vessels, and Ford is investing $1 billion in EV production in Europe.
Read MorePlus, Disney shares are down even after posting a surprise profit, the Biden administration secured 100 million more doses each of the Moderna and Pfizer COVID-19 vaccines, and Carl Icahn disclosed a stake in Bausch Health.
Read MorePlus, ADP said private companies added 174,000 jobs in January, Vaxart shares are down on concerns over a lackluster immune response to its COVID-19 vaccine, and Capri Holdings delivered an earnings beat.
Read MorePlus, Novavax said its coronavirus vaccine was shown to be 89.3% effective at preventing the U.K. variant, GameStop is up again, and crypto Dogecoin rose as much as 800% this morning.
Read MoreThe WallStreetBets group on Reddit mobilized around GameStop and several other of heavily shorted stocks this week, pushing them to jaw-dropping highs. And these 6 stocks might be the next names to rocket higher on a short squeeze.
Read MorePlus, Johnson & Johnson delivered an earnings beat, Regeneron said its COVID-19 antibody cocktail appears to be effective as a passive vaccine, and Bed Bath & Beyond got two downgrades this morning.
Read MorePlus, President Biden is pushing Congress to approve a new round of stimulus, Moderna said it’s working on a COVID-19 vaccine booster shot, and AMC has raised enough to avoid bankruptcy in the medium term.
Read MorePlus, Eli Lilly’s antibody therapy was found to reduce nursing home residents’ risk of symptomatic COVID-19 by 80%, United Airlines reported an earnings miss, and bitcoin is continuing to fall lower.
Read More